Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome

Abstract

In patients with severe CHD, the leptin/adiponectin ratio was not found to be a robust tool to distinguish patients with and without insulin resistance and those with and without the metabolic syndrome.